Key Honors & Roles

• Elected Member, European Academy of Sciences (2024)
• Top Global Scientist, State Council Special Allowance Recipient
•  Director, Guangdong Provincial New Tumor Vaccine Engineering Laboratory & Key Laboratory for Targeted Tumor Therapeutics
• Former Director, Biological Therapy Center, Sun Yat-sen University Cancer Center

Research Focus

– Gene Therapy & Tumor Immunotherapy: Pioneered translational research in oncolytic viruses, CAR-NK, and stem cell therapies.
Drug Innovation: Led development of China’s “first Phase III-ready gene therapy drug” (recombinant human endostatin adenovirus) and autologous
NK cell therapies.

Academic Leadership

•  Authored “180+ SCI papers (Nature Medicine, PNAS, JCI, H-index 58).
• Holds “50 patents”( U.S., PCT, China) in gene therapy and oncology.
• Chief Editor of “national textbooks (Molecular Virology*, 3 editions) and monographs (Cancer Personalized Medicine).

Major Awards

• National Science & Technology Progress Award (2nd Class), 2016
• Ministry of Education Natural Science Award (1st Class), 2011
• Guangdong Science & Technology Progress Award (1st Class), 2010, 2015

Translational Impact

• Spearheaded ,China’s first multi-target oncolytic virus and CAR-NK therapies from lab to market.
• Media Spotlight: Featured on *CCTV, China Education TV for breakthroughs in cancer biotherapy.

Global Engagement

• Senior Member, American Gene & Cell Therapy Association
• Former President, Asia-Pacific Gene & Cell Therapy Associate.